Obstetrics & Gynecology Doctors in Tallmadge, OH Accepting Medicare

7 Obstetrics & Gynecology doctors found. Showing 1 - 7

Jaclyn Flickinger, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 Northwest Ave, Tallmadge, OH 44278 Phone: 330-633-1350    Fax: 330-633-6068

Dr. Nisrine Zahir, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 Northwest Ave, Tallmadge, OH 44278 Phone: 330-633-1352    Fax: 330-633-6068

Steven Matthew Gorsuch, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 Northwest Ave, Tallmadge, OH 44278 Phone: 330-633-1352    Fax: 330-633-6068

Dr. Ahmad Khaled Jadallah, M.D. Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 121 Northwest Ave, Tallmadge, OH 44278 Phone: 330-633-1352    Fax: 330-633-6068

Dr. John Nelson Hutzler Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 Northwest Ave, Tallmadge, OH 44278 Phone: 330-633-1352    Fax: 330-633-6068

Philip John Smelcer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 Northwest Ave, Tallmadge, OH 44278 Phone: 330-633-1350

Dr. Sarah Babai, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 Northwest Ave, Tallmadge, OH 44278 Phone: 330-633-1352    Fax: 330-633-6068

News Archive

WTSI announces new technique to reprogramme human cells

Researchers from the Wellcome Trust Sanger Institute today announce a new technique to reprogramme human cells, such as skin cells, into stem cells. Their process increases the efficiency of cell reprogramming by one hundred-fold and generates cells of a higher quality at a faster rate.

Despite high mortality rates, cancer screenings are low in Sub-Saharan Africa

According to the World Health Organization, cervical cancer is the fourth most common form of cancer affecting women worldwide, and those in developing countries face a higher risk of dying from it.

Researchers identify tumor suppressor genes that drive subset of melanomas

Of the hundreds of genes that can be mutated in a single case of melanoma, only a handful may be true "drivers" of cancer. In research that appeared today in Nature Genetics, a Weizmann Institute of Science team has now revealed one of the drivers of a particularly deadly subset of melanomas - one that is still seeing a rise in new cases. This gene is a newly identified member of a group of genes called tumor suppressor genes.

MDA awards Repligen $1.4M for research of new compound with therapeutic potential for SMA

The Muscular Dystrophy Association today announced it has awarded $1.4 million in new research funding to the biopharmaceutical firm Repligen of Waltham, Mass., to complete the preclinical work needed to begin human clinical trials of a promising therapeutic compound for spinal muscular atrophy (SMA).

Read more Medical News

› Verified 2 days ago